We are thrilled to announce that Medistim will be officially launching the INTUI Software Platform at the 10th International Coronary Congress (ICC 2024) in London, taking place from December 12-14. This prestigious event brings together the world’s leading cardiac surgeons, making it the perfect venue to unveil INTUI —our most significant product innovation in a decade..
“Developed and tested in collaboration with an international team of cardiac surgeons, we are confident that INTUI offers advanced support for clinical decision-making, with the potential to improve patient safety and outcomes,” said Kari E. Krogstad, President and CEO of Medistim. “Our mission is to equip surgical teams with tools that simplify complex procedures, delivering exceptional ease of use. And this is just the beginning—we are excited to expand this technology to vascular applications in the near future.”
Mark your calendars for December 13th, when Medistim will host an exclusive symposium dedicated to introducing the INTUI platform. The agenda is packed with insightful presentations and interactive experiences designed to showcase how INTUI is set to enhance intraoperative surgical guidance and quality assessment.
Friday 13 December 2024 | 12:00-13:30 | QEII Centre, Whittle Room
The INTUI Software Platform combines Medistim’s proven TTFM technology with High-Frequency Ultrasound (HFUS) to provide surgeons with unparalleled precision, real-time insights, and a seamless, user-friendly interface. At this symposium, you’ll see firsthand how INTUI empowers surgeons to make more informed decisions, enhancing surgical outcomes and patient safety.
Built on a future-proof software architecture, INTUI sets a new standard for Medistim’s MiraQ™ platform. Its redesigned user interface is engineered to enhance procedural efficiency in surgery, offering simplified navigation, quicker access to critical data, and improved data interpretation—ultimately streamlining workflow and optimizing performance.
See you in London!
We are thrilled to announce that Medistim will be officially launching the INTUI Software Platform at the 10th International Coronary Congress (ICC 2024) in London, taking place from December 12-14. This prestigious event brings together the world’s leading cardiac surgeons, making it the perfect venue to unveil INTUI —our most significant product innovation in a decade..
“Developed and tested in collaboration with an international team of cardiac surgeons, we are confident that INTUI offers advanced support for clinical decision-making, with the potential to improve patient safety and outcomes,” said Kari E. Krogstad, President and CEO of Medistim. “Our mission is to equip surgical teams with tools that simplify complex procedures, delivering exceptional ease of use. And this is just the beginning—we are excited to expand this technology to vascular applications in the near future.”
Mark your calendars for December 13th, when Medistim will host an exclusive symposium dedicated to introducing the INTUI platform. The agenda is packed with insightful presentations and interactive experiences designed to showcase how INTUI is set to enhance intraoperative surgical guidance and quality assessment.
Friday 13 December 2024 | 12:00-13:30 | QEII Centre, Whittle Room
The INTUI Software Platform combines Medistim’s proven TTFM technology with High-Frequency Ultrasound (HFUS) to provide surgeons with unparalleled precision, real-time insights, and a seamless, user-friendly interface. At this symposium, you’ll see firsthand how INTUI empowers surgeons to make more informed decisions, enhancing surgical outcomes and patient safety.
Built on a future-proof software architecture, INTUI sets a new standard for Medistim’s MiraQ™ platform. Its redesigned user interface is engineered to enhance procedural efficiency in surgery, offering simplified navigation, quicker access to critical data, and improved data interpretation—ultimately streamlining workflow and optimizing performance.
See you in London!
Økernveien 94, Oslo Norway
Org. nr: 936 656 013
(C) 2024 Medistim ASA